STAT3 and ovarian cancer: The CHRF-miR-10b axis exerts a significant influence on cisplatin resistance in ovarian cancer (OC) through the regulation of the epithelial-mesenchymal transition (EMT) process and the STAT3 signaling pathway (Tan et al., 2020).